Micron Technologys Path to a TrillionDollar Valuation An Analysis Warren Buffetts Tiny Purchase Hint in March May Be Confirmed by Latest Berkshire Filing Sebi Proposes Intraday Option Strike Additions to Manage Market Volatility Vickers Report Highlights Insider Trading Activity on May 27 2026 YearEnd Portfolio Adjustments Key Moves for Stock Market Investors Shell SHEL Upgraded to Buy Following Transaction with ARC Resources VTVT Q1 2026 Earnings Massive EPS Surprise Driven by a NonRecurring Gain KRMD Q1 2026 Earnings NarrowerThanExpected Loss Highlights Operational Discipline Biohaven Ltd BHVN Q1 2026 Earnings Wider Loss Than Expected as PreRevenue Biotech Advances Pipeline Nayax Ltd NYAX Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Strong Operational Momentum FFAI Q1 2026 Earnings Narrowed Losses Beat Estimates but No Revenue Reported and Stock Drops 981 vTv Therapeutics Q1 2026 Earnings Strong EPS Surprise Driven by NonOperating Items Stock Declines Stellus Capital Investment Corporation SCM Edges Lower Amid Sector Headwinds nVent Electric NVT Holds Steady Near 165 Testing Key Resistance Zone iSpecimen ISPC Faces Renewed Selling Pressure Tests Key Support Near 328 Sphere Entertainment SPHR Fades From Resistance A Test of Support Levels Mamas Creations Inc MAMA Holds Ground Amid Sector Rotation NATO Defense Spending Set to Surge as US Pledges Additional Troops to Poland INDB Q1 2026 Earnings Small EPS Miss Meets Modest Stock Uptick ProDex Inc PDEX Edges Higher Amid Tight Trading Range MSA Safety Q1 2026 Earnings EPS Surpasses Estimates with Strong Operational Performance Carriage Services Inc CSV Q1 2026 Earnings Modest EPS Beat Amid Flat Revenue and Negative Stock Reaction KOD Q1 2026 Earnings EPS Beat Despite No Revenue Stock Slips EME Q1 2026 Earnings EPS Surges 1487 Above Estimates Stock Gains EVH Q1 2026 Earnings EPS Beat Drives Positive Stock Reaction Amidst Disciplined Cost Management Park Hotels Resorts Q1 2026 Earnings Stellar EPS Surprise of 76957 Drives Positive Sentiment Instil Bio Inc TIL Q1 2026 Earnings WiderThanExpected Loss as Biotech Continues PreCommercial Phase